US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

3  4  5  6    8    10  11  12  
Biotech Equipment Update February 2014
2/1/2014 | published by: Worldwide Videotex
Biotech Equipment Update covers news and the latest information about biotechnology lab and manufacturing equipment and products. This includes new product and technology announcements, as well as vendor research, development, and manufacturing information.  |  read more...
$25.00
Medivation Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... you require to better understand Intermune and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
$995.00
Nektar Therapeutics Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... the information you require to better understand Nektar Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up ...  |  read more...
$995.00
Genetic Disorders Partnering Terms and Agreements
2/1/2014 | published by: Current Partnering
... are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. ...  |  read more...
$2,995.00
Global Next Generation Sequencing Market: Trends & Opportunities (2013-2018)
2/1/2014 | published by: Daedal Research
... market. The report also provides detailed analysis of the global next generation sequencing market, the Sanger Sequencing market and provides specific focus on the clinical diagnostic opportunities of the NGS technology. The report also profiles ...  |  read more...
$800.00
Clinical Stage Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
$1,495.00
Elan Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... you require to better understand Elan and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
$995.00
Biotech Financial Reports February 2014
2/1/2014 | published by: Worldwide Videotex
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements.  |  read more...
$25.00
Genomics Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
$1,495.00
Worldwide Biotech February 2014
2/1/2014 | published by: Worldwide Videotex
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry.  |  read more...
$25.00
Public Health Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
$1,495.00
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech
2/1/2014 | published by: Current Partnering
... and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the ...  |  read more...
$3,295.00
Alkermes Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... you require to better understand Alkermes and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
$995.00
Novartis Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
$995.00
Gilead Sciences Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding ...  |  read more...
$995.00
Humira (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
$3,495.00
Freedonia Focus on Enzymes: United States
1/31/2014 | published by: Freedonia Focus Reports
... nucleases, and other enzymes. Total demand is also segmented by market as follows: biofuel production, food and beverage, cleaning product, other industrial markets, research and biotechnology, and other specialty markets. To illustrate historical trends, total ...  |  read more...
$600.00
Genentech, Inc. - Product Pipeline Review - 2014
1/31/2014 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Genentech, Inc.’s corporate ...  |  read more...
$1,500.00
Bayer CropScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
1/31/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Agilent Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
1/31/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Agilent Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Generex Biotechnology Corporation - Product Pipeline Review - 2014
1/31/2014 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
1/31/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
RTI Biologics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
1/31/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' RTI Biologics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
PTC Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
1/31/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' PTC Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
$350.00
Galapagos NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
1/31/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Galapagos NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
$350.00
3  4  5  6    8    10  11  12  
 
Our Clients